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ABSTRACT
Objectives To assess timeliness of carotid
endarterectomy services in the United Kingdom.
Design Observational study with follow-up to March
2008.
Setting UK hospitals performing carotid endarterectomy.
Participants UK surgeons undertaking carotid
endarterectomy from December 2005 to December 2007.
Main outcome measures Provision and speed of delivery
of appropriate assessments of patients; carotid
endarterectomy and operative mortality; 30 day
postoperative mortality.
Results 240 (61% of those eligible) consultant surgeons
took part from 102 (76%) hospitals and trusts. Of 9913
carotid endarterectomies recorded on hospital episode
statistics, 5513 (56%) were included. Of the patients who
underwent endarterectomy, 83% had a history of
transient ischaemic attack or stroke. Of these recently
symptomatic patients, 20% had their operation within
two weeks of onset of symptoms and 30% waited more
than 12 weeks. Operative mortality was 0.5% during the
inpatient stay and 1.0% (95% confidence interval 0.7% to
1.3%) by 30 days.
Conclusion Only 20% of symptomatic patients had
surgerywithin the twoweek target time set by theNational
Institute for Health and Clinical Excellence (NICE).
Although operative mortality rates are comparable with
those in other countries, some patients might experience
disabling or fatal stroke while waiting for surgery and
hence not be included in operative statistics. Major
improvements in services are necessary to enable early
surgery in appropriate patients in order to prevent
strokes.
INTRODUCTION
Every year in theUnitedKingdom, about 120 000 peo-
ple have a stroke and 20-30% die within a month.
Stroke is also the single largest cause of severe disabil-
ity in adults, with nearly a million people living with
the after effects of stroke, a third of whom have long
term disability. Stroke costs the economy £7bn (€8bn,
$11bn) a year: £2.8bn in direct hospital care, £2.4bn in
costs of informal care, and £1.8bn in lost productivity.1
Outcomes in the UK have been poor compared with
other Western, particularly European, countries.2
Pooled analysis of data from individual patients from
the randomised controlled trials of endarterectomy
versus medical treatment alone for symptomatic caro-
tid stenosis showed that surgery reduced the risk of
stroke in patients with 50-99% carotid stenosis3 but
that the benefit decreased substantially if surgery was
delayed for more than two weeks after the presenting
event.4 In 2004, however, the RCP Sentinel Audit
reported that only half of stroke patients had carotid
imaging within 12 weeks.5 Delays between imaging
and subsequent surgery were not recorded. An
Oxfordshire study found median time from transient
ischaemic attack or stroke to imaging was over four
weeks and median delay to surgery was 14 weeks.6
Randomised patients from the UK in a recent trial of
local versus general anaesthetic had a 12 week delay to
surgery,7 and similar delays were reported in an audit
of all symptomatic endarterectomy patients in Scot-
land in 1997-9 and again in 2005-7.89 The 2006 RCP
Sentinel Audit showed some improvement in speed of
diagnosis, investigation, and treatment of transient
ischaemic attack and stroke,10 but delays in investiga-
tion and treatment were still excessive. Although
delays to surgery have been reduced substantially in
some centres,11 there are no published data on current
performance nationally.
In the UK, around 4500 carotid endarterectomies
are performed each year, but it is not known how
many patients have had preceding symptoms and
how long they have had to wait for operation. Each
operation costs just over £300012 (€3380, $4500), but
no cost effectiveness analysis has been done to deter-
mine whether the procedures, as performed in theUK,
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effectively prevent future strokes. Many more carotid
endarterectomies are done in other countries; Canada
does eight times, Australia 10 times, and the United
States up to 30 times asmany carotid endarterectomies
per 100 000 population,1 although many of these pro-
cedures are for asymptomatic carotid stenosis.
The purpose of the UK Carotid Endarterectomy
study was to assess the quality of carotid endarterect-
omy services and themortalitywithin 30days of opera-
tion. The study was organised in two parts. Part 1
comprised two surveys inDecember 2005 andDecem-
ber 2006 describing the organisation of care within the
UK. Part 2 was a clinical study of patients undergoing
surgery between 1 December 2005 and 31 December
2007, with follow-up completed by 31March 2008, the
results of which are presented here.
METHODS
We contacted every acute hospital in England, Wales,
Scotland, and Northern Ireland to ascertain the num-
ber of surgeons who performed carotid endarterect-
omy and wrote to each individually and invited them
to participate. We also obtained data for each trust
(each hospital in Scotland) from the hospital episode
statistics or equivalent body for each country to use
for comparison.
Surgeons were asked to submit all data on all carotid
endarterectomies they performed over the study per-
iod (December 2005 to December 2007) via a web
based tool whose definitions (help text) were accessible
online. All required data items were collectable within
the hospitals’ routine systems, and anonymous codes
were used to protect the identities of patients, surgeons,
and hospitals. Professionals submitting the data
included surgeons, nurse specialists, specialist regis-
trars, and clinical fellows. Overall responsibility for
the data quality lay with the surgeon who performed
the operation. In cases where the patient was assessed
by the surgeon who performed the operation, we
sought no external validation. The web tool contained
mandatory fields and online data logic/consistency
checks, which ensured the “minimum dataset” was
fully completed and good data quality submitted.
For each operation, we collected data in two phases:
preoperative and operative data up to discharge (phase
1) and data on 30 day survival and follow-up outcome
assessment (phase 2) (box).
Once phase 1 was completed and actively submitted
for analysis, the relevant sections were “locked.” Phase
2 questions were accessible only once phase 1 was suc-
cessfully completed. To cater for variations between
the patients’ review times, we allowed a period of
three months. The minimum criterion for inclusion of
a case in the analyses was completion of phase 1.
RESULTS
We identified 396 eligible surgeons, and 240 (61%)
contributed cases to the study. The median number
of cases per surgeon was 18 (interquartile range 8-32).
In this study we have included only those patients who
underwent surgery.We do not knowhowmany opera-
tions were cancelled because the carotid stenosis had
Table 1 | Regional contributions to survey by country and hospital/trust
Region
HES (based on contributing hospitals only) Eligible hospitals/trusts Eligible surgeons
No of patients
No (%) of cases contributed for
this round by 31 March 08
No of
hospitals
No (%) contributing at least one
case by 31 March 2008
No of
surgeons
No (%) contributing at least one
case by 31 March 2008
England 7056 4718 (67) 114 88 (77) 341 211 (62)
N Ireland 324 162 (50) 3 3 (100) 10 8 (80)
Scotland 793 376 (47) 9 7 (78) 26 12 (46)
Wales 530 234 (44) 9 4 (44) 19 9 (47)
UK/total 8703 5497 (63) 135 102 (76) 396 240 (61)
HES=hospital episodes statistics.
Clinical data
Phase 1 (preoperative and operative data up to discharge)
Demographics (date, hospital code, patient’s date of birth, sex, ethnicity)
Admission (date, mode of entry, such as elective)
History (diabetes, ischaemic heart disease, smoking, hypertension)
Referral (source, date)
Indications (symptoms, when they occurred)
Imaging at time of referral (date, type, stenosis, brain imaging)
Confirmatory carotid imaging before operation (date, type, stenosis)
Most recent symptom and neurological status before surgery (time, Rankin score)
Previous carotid intervention (surgery, angioplasty)
Preoperative tests (electrocardiography, blood pressure, blood tests)
Preoperative drug use (aspirin, clopidogrel, dipyridamole, warfarin, statins, β blockers)
Operation (date, side, grade of surgeon, type of anaesthetic, anaesthetist grade)
Procedure (time taken, use of shunt, patch, tacking sutures)
Level of postoperative care (such as high dependency unit)
Complications and timing (myocardial infarct, stroke, death, other, such as cranial nerve
damage)
Discharge (date, destination, Rankin score)
Phase 2 (30 day survival and follow-up outcome assessment)
Patient status at 30 days (dead, date, cause)
Follow-up visit (offered, attended, date, seen by whom)
Complications (reoperation, date, cranial nerve injury, stroke (including date), Rankin
score)
Drug use (aspirin, clopidogrel, dipyridamole, warfarin, statin, β blocker)
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progressed to occlusion before surgery or how many
patients had a disabling or fatal stroke before they
could undergo surgery.
Phase 1 details were complete for 5513 patients
(including 16 from the private sector) by 31 March
2008 (from 240 surgeons in 120 hospitals). Baseline
phase 2 data were available for 4964 cases (from 206
surgeons in 105 hospitals), and complete data were
available for the 4404 patients who attended follow-
up appointments. The total number of cases listed on
hospital episode statistics as “carotid endarterectomy
with orwithout patching” for the data collection period
of this study was 9913, giving a 56% rate of case sub-
mission (table 1). In England, monthly case ascertain-
ment compared with hospital episode statistics data
(figure) remained constant across the data collection
period.
Of the 5513 patients, 3751 (68%) were men, with
mean age of 70 (71 for women). Twelve per cent of
all patients were aged over 80 (660/5513), 2.9% over
85 (160/5513), and 0.6% over 90 (31/5513). Most
patients were British white (95%, 5115/5377), the
next largest group being British Asian (1.1%, 58/
5513), which is consistent with the known predomi-
nance of carotid disease in the white population.
Twenty one per cent (1178/5509) had diabetes, and
32% (1762/5513) had a history of ischaemic heart dis-
ease or chronic heart failure. Thirty one per cent
(1671/5476) were current smokers. The commonest
risk factor for stroke, hypertension, was present in
80% of patients (4403/5492), with 1.4% (79/5492)
untreated on admission.
Sixteen per cent of cases (889/5513) were recorded
as being asymptomatic, with the 84% remaining hav-
ing some symptom attributable to carotid disease. Of
these, 41% (1914/4624) had a transient ischaemic
attack, 35% (1634/4624) had stroke, 20% (916/4624)
had amaurosis fugax, and 3% (160/4624) none of
these three symptoms. Previous ipsilateral carotid sur-
gery was recorded for 1.8% (99/5513) of patients and
angioplasty for 0.4% (20/5513).
The referral sourcewas recorded for all cases. Stroke
(38%, 2117/5513) or care of the elderly (13%, 717/
5513) physicians referred most patients, with neurolo-
gists (11%, 596/5513) and general practitioners (13%,
701/5513) referring substantial numbers. The 1382
other referrals came from sources including cardio-
logists, ophthalmologists, and other vascular surgeons.
The fastest pathway from referral to surgery was
through neurologists (median delay 25 days,
interquartile range 10-63 days) and stroke physicians
(30, 16-67 days). Referrals through care of the elderly
physicians (48, 24-85 days) and general practitioners
(68, 34-151 days) were considerably slower.
There was considerable delay between the most
recent symptom and surgery (table 2). Nearly a third
(1372/4591) of patients waited more than 12 weeks,
and only 20% (944/4591) underwent surgery within
two weeks.
Delays from referral to operationwere considerable.
Themedian delay from referral to surgery was 40 days
(17-84 days). During the survey there was a trend
towards reduction in this delay from 43 (19-88) to 38
(16-81) to 34 (13-79) days (dividing the data collection
into three equal time periods). Once admitted, 15%
(818/5513) had their operation on the day of admis-
sion, and 94% (5186/5513) were operated on within
two days.
Preoperatively, 90% of patients were taking a statin
(4982/5513) and 32% (1781/5512) were taking a β
blocker. Nearly all (5378/5513) were taking at least
one antithrombotic drug before surgery (table 3). Anti-
platelet therapy was stopped before surgery in 11%
(514/4627) of those taking aspirin and 51% (468/922)
taking clopidogrel (usually in addition to aspirin). Five
per cent (289/5363, 15 missing data) were taking war-
farin, which was almost always stopped (273/284,
96%) before surgery (table 3).
Surgery on the left carotid artery was slightly more
common (52%, 2863/5504; datamissing for nine) than
on the right. Some 3733 patients underwent confirma-
tory imaging (a second ultrasound examination after
the initial duplex scan to confirm that the carotid artery
was still patent before surgery) of the ipsilateral carotid
before operation, and the level of stenosiswas available
for all but 16 cases. Seven per cent (269/3717) of
patients had 50-69% stenosis, 55% (2032/3717) had
70-89% stenosis, and 35% (1285/3717) had 90-99%.
One per cent (28/3717) had less than 50% stenosis,
and 3% (103/3717) were ungraded. The level of steno-
sis in the contralateral carotid arterywasmissing for 25
cases and not imaged in 1075 cases. Fifty six per cent of
cases (1462/2633) had less than 50% contralateral ste-
nosis, 14% (381/2633) had a level of 50-69%, 19%
(498/2633) had 70-99%, and 11% (292/2633) had an
occluded artery. The methods used to assess duplex
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Table 2 | Delay between most recent symptom and surgery
Delay (weeks) No of cases* (%)
≤2 944 (20)
2-4 654 (14)
>4-12 1621 (34)
>12 1372 (30)
*Total=4591; 33 missing.
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stenosis were not specified, but, in the organisational
surveys, hospitals were found to have used different
methods (NASCET (North American symptomatic
carotid endarterectomy trial), ECST (European caro-
tid surgery trial), and common carotid artery (CCA)),
which could result in variation in stenosis; however,
this was not the only assessment of the stenosis, and
magnetic resonance angiography (MRA) and com-
puted tomography angiography (CTA) were often car-
ried out, contributing to the decision to undertake
surgery.
Phase 2 (follow-up) data were known for 4964 (90%)
patients. Ninety five per cent (4593/4818) were offered
an appointment, and, of these, 96% (4404/4593)
attended, with median time from operation to follow-
up of 50 days (41-65 days). Rankin scores at follow-up
were known for 4389 patients andwere broadly similar
to the scores at discharge (data not shown; they are less
reliable because theymeasure a broad range of disabil-
ity, which is not necessarily related to stroke).
Most patients (91%, 4499/4964) were taking anti-
thrombotic drugs, the type being specified for 4471:
aspirin in 85%, clopidogrel or dipyridamole, or both,
in 35%, and warfarin in 5%, despite about 17% of
patients having atrial fibrillation (table 3). Eighty four
per cent (4158/4964) were taking statins, and 21%
(1054/4934) were taking β blockers.
Inpatient mortality was 0.5% (29/5512). The princi-
pal cause of inpatient death was stroke, followed by
myocardial infarction. Risk of inpatient death
increased with age (0.1% (1/820) at <60 years, 0.6%
(23/4032) at 60-80 years, 0.8% (5/660) at >80 years.
The 30 day mortality was 1.0% (48/4944); 30 day
survival was not known for seven patients. Of the
5512 patients, 101 (1.8%) were reported to have had a
stroke as an inpatient and of these 67 had the stroke
within 24 hours of surgery, which gives a 24 hour
stroke rate of 1.2%. Thirty patients had a stroke after
discharge, three of whomhad already had a stroke dur-
ing their inpatient stay. The rate of stroke from admis-
sion to follow-up was 2.6% (124/4681) (table 4).
DISCUSSION
This large survey of carotid endarterectomypractice in
the UK shows that the operation is underused com-
pared with other similar countries. Surgeons abroad
might be driven by “fee for service” and certainly per-
formmanymore operations for asymptomatic disease.
It is possible, however, that of the 120 000 people who
have a transient ischaemic attack or stroke every year
in the UK at least 10 000 might be suitable candidates
for carotid endarterectomy yet only 4500 procedures
are being performed each year. There are no data indi-
cating the specific suitability of stroke patients for sur-
gery, but current use in Scotland is estimated at 4-5%.9
Comparison with other studies
Studies of performance of endarterectomy in the UK
have been published over the past 10 years,6-8 13 but an
up to date survey was required for several reasons. It
has only recently been fully appreciated that the risk of
major stroke is high during the first few days andweeks
after a transient ischaemic attack or non-disabling
ischaemic stroke.14 15Delays to carotid endarterectomy
are therefore associated with a high risk of stroke
before surgery,6 and the benefit of surgery conse-
quently falls rapidly with increasing delay.4 There
have also been major changes in clinical practice in
recent years, including changes in theway that patients
being considered for carotid endarterectomy are inves-
tigated, changes in operative and anaesthetic proce-
dures, and the increasing use of carotid stenting
instead of surgery.16
Recently published NICE guidelines suggest that
carotid endarterectomy should be performed in appro-
priate patients within two weeks of presenting symp-
toms. The most important finding of our survey is the
unacceptable delays between symptom and operation
in the UK. Indeed, if our results are compared with
previous studies, there is little evidence of improve-
ment since those data were published supporting the
need for earlier surgery.
Two prospective population based studies identified
all patients undergoing carotid imaging for transient
ischaemic attack or stroke in Oxfordshire (population
studied 680 772) in 2002-3 and in theOxfordVascular
Study (OXVASC) subpopulation (population 92 000)
in 2002-4.6 Among 853 patients who had carotid ima-
ging in the Oxfordshire population, median (inter-
quartile range) times from presenting event to
referral, scanning, and endarterectomy were 9 (3-30),
33 (12-62), and 100 (59-137) days, respectively. Forty
nine patients had endarterectomy, but only three (6%)
had surgery within two weeks of their presenting event
Table 3 | Proportion of antithrombotic drug use before and
after endarterectomy
Drug (s)
Preoperative
(n=5513)
Postoperative
(n=4471)
Aspirin 60.5 49.9
Clopidogrel 7.0 6.2
Dipyridamole 1.2 1.9
Aspirin + dipyridamole 18.7 24.7
Aspirin + clopidogrel 7.3 9.8
Clopidogrel + dipyridamole 0.4 0.5
Warfarin 4.8 5.0
Any combination of antiplatelet
drugs
95.1 94.2
Any antiplatelet + warfarin 99.9 99.2
Table 4 | Reported outcomes and complications. Figures are percentages (numbers) of
patients
Outcome/complication Inpatient
Inpatient/within 30 days of
surgery
Death 0.5% (29/5512) 1.0% (48/4944)
Stroke 1.8% (101/5512)* 2.6% (124/4681)†
Death/stroke 2.1% (118/5512) 2.5% (124/4918)
*“Perioperative” as classified by surgeons retrospectively.
†Strokes after discharge could be reported at any point. Date recorded in 24/30; 18 occurred within 30 days of
operation, but as date missing for six, total within 30 days could be as high as 24.
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and only 21 (43%) within 12 weeks. Risk of stroke
before endarterectomy in those with 50-99% stenosis
was 32% (17-47%) at 12 weeks, and half the strokes
were disabling or fatal.
In the recent GALA trial (multicentre randomised
trial of general versus local anaesthesia for carotid
endarterectomy) the first 1001 UK patients rando-
mised had amedian delay between symptoms and sur-
gery of 82 days.7
There were differences in speed of referral from dif-
ferent physicians in our survey. Neurologists and
stroke physicians might have speedier access to ima-
ging facilities than other specialties and some have
dedicated joint transient ischaemic attack and stroke
clinics shared with vascular surgeons as well as regular
multidisciplinary team meetings. Other specialties are
less “stroke” orientated, and this might explain their
slower service, but implementation of new stroke poli-
cies shouldhelp to reducedelays, especially if common
pathways are streamlined within new services.
A prospective independent survey of all carotid
endarterectomies was performed in Scottish National
Health Service hospitals over two 13 month periods
from September 1997 and February 1999.8 Thirteen
hospitals performed 485 carotid endarterectomies in
the first period and 392 in the second, equating to an
overall annual rate of 79 permillion population.During
both periods at least 95% of operations were done for
symptomatic carotid stenosis. About 40% of patients
were seen by a surgeon within two weeks of referral, of
whom only about 40% were operated on within one
month thereafter.More recent updates of carotid endar-
terectomy in Scotland took place in 2005 and 2007;
these took into consideration the published SIGN
guidelines (not including 2008) and NHSQIS (National
Health ServiceQuality Improvement Scotland) clinical
standards and reported on the 482 interventions (448
carotid surgery) performed in 2005. The mean time
from referral to seeing the surgeon was 10.8 days, with
amean time fromsurgical consultation to surgery of just
over three weeks (22.5 days). Overall, only 38% had
their intervention within the Scottish target of 30 days.
9This is similar toour findings of34%beingoperatedon
within four weeks of their symptoms (table 2).
Implementing faster surgical referral
The Department of Health’s stroke strategy now
recommends that carotid surgery should be carried
out within 48 hours of symptoms, when the risk of
stroke is highest, in patients with transient ischaemic
attack or minor stroke who are neurologically
stable.17 To achieve this, the use of FAST (Face Arm
Speech Test) might help the public to recognise transi-
ent ischaemic attack and early stroke,17 and the
ABCD2 score18 will help primary and secondary care
services to identify those patients with transient ischae-
mic attack who are at highest risk of stroke. Imaging
services will need to provide carotid ultrasonography
seven days aweek, and carotid surgery in symptomatic
patients will need to be regarded as an urgent proce-
dure, having precedence over elective cases. A weekly
multidisciplinary teammeeting to assess suitability for
surgery will be insufficient because operations will
need to be scheduled for the next day. Anaesthetic
staff with a special interest in vascular anaesthesia will
also need to be available at short notice.
Operativemortality in our studywas about 1%and is
comparable with large randomised controlled trials of
endarterectomy for symptomatic carotid stenosis,3 4
and with systematic reviews of published surgical case
series.19 20 In the Scottish Audit from 2007, the 30 day
mortality was 3% (95% confidence interval 1% to 5%)
and the risk of strokewithin 30daysof interventionwas
5% (2% to 6%).9 Some deaths and strokes occur after
discharge, and, in our survey, half the deaths occurred
outside hospital. Strokes are under-reported when sur-
geons report their own operative outcomes, and the
risk of death and non-fatal stroke in our survey (2.5%)
is much lower than that in symptomatic trials with
independent assessment of patients by neurologists or
stroke physicians. Most patients (75%) in the 2007
Scottish Stroke Care Audit were followed up in a neu-
rovascular clinic, and in the future stroke physicians
and neurologists (especially outside Scotland) should
improve their service by providing independent
assessment before discharge and at final outpatient fol-
low-up.9 21 22
Earlier operation in symptomatic patients will have
lasting benefit on stroke prevention.4 23 24 If possible
more symptomatic patients should be fast tracked,
allowing them to benefit from early surgery. Further
research is required to identify the appropriate propor-
tion of younger (up to 75 years) patients with asympto-
matic stenosis in whom prophylactic surgery will
provide cost effective stroke-free survival.25 26
Limitations of study
As with all studies of this nature, it is important to
acknowledge the limitations. The data were self
reported by the proportion (61%) of UK surgeons
who took part and a considerable number of surgeons
did not contribute for various reasons. A comparison
with the Scottish data for the same period suggests that
WHAT IS KNOWN ABOUT THIS TOPIC
Stroke and transient ischaemic attack are common causes of death and disability in the UK
Many patients do not report symptoms of transient ischaemic attack orminor stroke promptly
and there is a high risk of stroke within 30 days
A considerable proportion of symptomatic patients have tight carotid stenosis
Early carotid endarterectomy after symptoms will effectively prevent future stroke
WHAT THIS PAPER ADDS
Most UK patients have carotid surgery after symptoms, but there are long delays between
symptoms and surgery
Only a fifth of symptomatic patients have surgery within the two weeks recommended by
NICE guidelines
Carotid endarterectomy for symptoms is urgent and should have priority over elective surgery
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the delays are similar but that stroke rates might be
under-reported.9 Some of the contributing surgeons
might not have submitted all their cases, if hospital epi-
sode statisics are correct, again calling into question the
apparently low operative risk of stroke. Not all the
patients in the survey attended a follow-up appoint-
ment and this might be another reason for the low
reported rates of complications. In addition, the survey
captured only those patients undergoing surgery and
there might have been other patients potentially eligi-
ble for carotid endarterectomywhodidnot receive sur-
gery. Nevertheless, the process data are likely to be
reasonably reliable and have important implications
for routine clinical practice, particularly in relation to
delays in investigation and treatment.
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